Bonstein Sara

Chief Financial Officer at INSM; CFO/COO at ONCOSEC MEDICAL Inc; Chief Financial Officer at Advaxis, Inc.

Sold, on record
$44.4M
Dollars the filings state
Form 4 sales
29
Latest Jun 3, 2026
Form 144 notices
5
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
4
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale INSMUnusual
    Jun 10, 2025 2025

    Sold 57,766 shares at $89.12 ($5.1M)

    Bonstein Sara, Chief Financial Officer

    10b5-1 planSold 35.8% of holdings ($14.4M position)103,412 shares left4.8x usual sizeFiling

  2. 2 Form 4 sale INSMUnusual
    Jun 23, 2025 +13 days

    Sold 57,765 shares at $101.78 ($5.9M)

    Bonstein Sara, Chief Financial Officer

    10b5-1 planSold 38.2% of holdings ($15.4M position)93,536 shares left4.4x usual sizeFiling

  3. 3 Form 4 sale INSMUnusual
    Jul 7, 2025 +14 days

    Sold 57,764 shares at $95.86 ($5.5M)

    Bonstein Sara, Chief Financial Officer

    10b5-1 planSold 40.7% of holdings ($13.6M position)84,017 shares left3.7x usual sizeFiling

  4. 4 Form 4 sale INSMUnusual
    Jul 21, 2025 +14 days

    Sold 58,400 shares at $102.67 ($6M)

    Bonstein Sara, Chief Financial Officer

    10b5-1 planSold 44.3% of holdings ($13.5M position)73,505 shares left3.2x usual sizeFiling

  5. 5 Form 4 sale INSMNo plan
    Jan 8, 2026 +171 days

    Sold 4,642 shares at $174.22 ($809k)

    Bonstein Sara, Chief Financial Officer

    No 10b5-1 planSold 5.5% of holdings ($14.8M position)80,506 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale INSMNo plan
    Feb 3, 2026 +26 days

    Sold 748 shares at $156.34 ($117k)

    Bonstein Sara, Chief Financial Officer

    No 10b5-1 planSold 0.9% of holdings ($12.6M position)79,758 shares left0x usual sizeFiling

  7. 7 Form 4 sale INSMNo plan
    May 13, 2026 +99 days

    Sold 8,272 shares at $116.18 ($961k)

    Bonstein Sara, Chief Financial Officer

    No 10b5-1 planSold 10.4% of holdings ($9.3M position)71,486 shares left0.5x usual sizeFiling

  8. 8 Form 4 sale INSMNo plan
    Jun 3, 2026 +21 days

    Sold 2,404 shares at $102.27 ($246k)

    Bonstein Sara, Chief Financial Officer

    No 10b5-1 planSold 3.4% of holdings ($7.3M position)69,082 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (34)

Form 144 notices and Form 4 sales by Bonstein Sara
Source
Jun 3, 2026Jun 5, 2026INSMChief Financial OfficerForm 4 sale2,404$246k3.4%No planSEC
May 13, 2026May 15, 2026INSMChief Financial OfficerForm 4 sale8,272$961k10.4%No planSEC
Feb 3, 2026Feb 4, 2026INSMChief Financial OfficerForm 4 sale748$117k0.9%No planSEC
Jan 8, 2026Jan 8, 2026INSMChief Financial OfficerForm 4 sale4,642$809k5.5%No planSEC
Jul 21, 2025Jul 23, 2025INSMChief Financial OfficerForm 4 sale58,400$6M44.3%UnusualSEC
Jul 7, 2025Jul 9, 2025INSMChief Financial OfficerForm 4 sale57,764$5.5M40.7%UnusualSEC
Jun 23, 2025Jun 25, 2025INSMChief Financial OfficerForm 4 sale57,765$5.9M38.2%UnusualSEC
Jun 10, 2025Jun 12, 2025INSMChief Financial OfficerForm 4 sale57,766$5.1M35.8%UnusualSEC
Jun 3, 2025Jun 4, 2025INSMChief Financial OfficerForm 4 sale1,579$113k1.4%No planSEC
May 14, 2025May 15, 2025INSMChief Financial OfficerForm 4 sale10,504$709k8.8%No planSEC
Feb 18, 2025Feb 20, 2025INSMChief Financial OfficerForm 4 sale18,322$1.5M13.4%RoutineSEC
Feb 12, 2025Feb 13, 2025INSMChief Financial OfficerForm 4 sale18,321$1.5M11.8%RoutineSEC
Feb 6, 2025Feb 7, 2025INSMChief Financial OfficerForm 4 sale28,390$2.3M15.4%UnusualSEC
Jan 10, 2025Jan 10, 2025INSMChief Financial OfficerForm 4 sale6,000$393k4.8%No planSEC
May 29, 2024May 30, 2024INSMChief Financial OfficerForm 4 sale241,288$12.1M67.3%UnusualSEC
May 28, 2024May 28, 2024INSMOfficerForm 144 notice241,288$12.1MNoticeSEC
May 14, 2024May 15, 2024INSMChief Financial OfficerForm 4 sale11,088$281k8.6%No planSEC
May 14, 2024May 14, 2024INSMOfficerForm 144 notice11,088$283kNoticeSEC
Jan 9, 2024Jan 11, 2024INSMChief Financial OfficerForm 4 sale4,497$131k3.8%No planSEC
Jan 5, 2024Jan 5, 2024INSMOfficerForm 144 notice9,294$271kNoticeSEC
Dec 22, 2023Dec 22, 2023INSMOfficerForm 144 notice13,199$396kNoticeSEC
Dec 22, 2023Dec 22, 2023INSMChief Financial OfficerForm 4 sale13,199$396k11.1%UnusualSEC
May 16, 2023May 17, 2023INSMChief Financial OfficerForm 4 sale3,820$72k3.1%No planSEC
May 15, 2023May 15, 2023INSMOfficerForm 144 notice8,577$166kNoticeSEC
Jan 10, 2023Jan 12, 2023INSMChief Financial OfficerForm 4 sale2,857$52k4.1%Plan not statedSEC
May 16, 2022May 18, 2022INSMChief Financial OfficerForm 4 sale1,433$27k2.6%Plan not statedSEC
Jan 11, 2022Jan 13, 2022INSMChief Financial OfficerForm 4 sale1,154$29k3.1%Plan not statedSEC
Jan 16, 2020Jan 21, 2020ONCOSEC MEDICAL IncCFO/COOForm 4 sale1,351$3k3.2%Plan not statedSEC
Oct 16, 2019Oct 18, 2019ONCOSEC MEDICAL IncCFO/COOForm 4 sale1,111$2k2.5%Plan not statedSEC
Jan 3, 2018Jan 3, 2018Advaxis, Inc.Chief Financial OfficerForm 4 sale5,224$17k2.3%Plan not statedSEC
Nov 6, 2017Nov 6, 2017Advaxis, Inc.Chief Financial OfficerForm 4 sale3,862$13k1.7%Plan not statedSEC
Nov 2, 2017Nov 2, 2017Advaxis, Inc.Chief Financial OfficerForm 4 sale12,734$41k5.2%Plan not statedSEC
Dec 30, 2016Jan 3, 2017Advaxis, Inc.Chief Financial OfficerForm 4 sale5,520$41k4.2%Plan not statedSEC
Feb 24, 2016Feb 25, 2016Advaxis, Inc.Chief Financial OfficerForm 4 sale15,037$84k15.8%Plan not statedSEC